NZ337754A - Leptospira pathogens belonging to the serogroup Hurstbridge or serovar Hurstbridge - Google Patents
Leptospira pathogens belonging to the serogroup Hurstbridge or serovar HurstbridgeInfo
- Publication number
- NZ337754A NZ337754A NZ337754A NZ33775498A NZ337754A NZ 337754 A NZ337754 A NZ 337754A NZ 337754 A NZ337754 A NZ 337754A NZ 33775498 A NZ33775498 A NZ 33775498A NZ 337754 A NZ337754 A NZ 337754A
- Authority
- NZ
- New Zealand
- Prior art keywords
- hurstbridge
- leptospira
- bacterium
- serogroup
- serovar
- Prior art date
Links
- 241000589902 Leptospira Species 0.000 title abstract 5
- 244000052769 pathogen Species 0.000 title 1
- 241000894006 Bacteria Species 0.000 abstract 3
- 230000001717 pathogenic effect Effects 0.000 abstract 2
- 208000017443 reproductive system disease Diseases 0.000 abstract 2
- 206010000234 Abortion spontaneous Diseases 0.000 abstract 1
- 206010055690 Foetal death Diseases 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 208000000509 infertility Diseases 0.000 abstract 1
- 231100000535 infertility Toxicity 0.000 abstract 1
- 230000036512 infertility Effects 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 239000000523 sample Substances 0.000 abstract 1
- 230000001932 seasonal effect Effects 0.000 abstract 1
- 208000000995 spontaneous abortion Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPO5494A AUPO549497A0 (en) | 1997-03-07 | 1997-03-07 | Novel bacterial pathogens |
| PCT/AU1998/000145 WO1998040099A1 (fr) | 1997-03-07 | 1998-03-06 | Pathogenes du type leptospira |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ337754A true NZ337754A (en) | 2000-10-27 |
Family
ID=3799797
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ337754A NZ337754A (en) | 1997-03-07 | 1998-03-06 | Leptospira pathogens belonging to the serogroup Hurstbridge or serovar Hurstbridge |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JP2002501368A (fr) |
| AU (1) | AUPO549497A0 (fr) |
| CA (1) | CA2283624A1 (fr) |
| NZ (1) | NZ337754A (fr) |
| WO (1) | WO1998040099A1 (fr) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050089533A1 (en) * | 2003-01-29 | 2005-04-28 | Joseph Frantz | Canine vaccines against Bordetella bronchiseptica |
| US8652782B2 (en) * | 2006-09-12 | 2014-02-18 | Longhorn Vaccines & Diagnostics, Llc | Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids |
| US9481912B2 (en) | 2006-09-12 | 2016-11-01 | Longhorn Vaccines And Diagnostics, Llc | Compositions and methods for detecting and identifying nucleic acid sequences in biological samples |
| US8097419B2 (en) | 2006-09-12 | 2012-01-17 | Longhorn Vaccines & Diagnostics Llc | Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009 |
| US8080645B2 (en) | 2007-10-01 | 2011-12-20 | Longhorn Vaccines & Diagnostics Llc | Biological specimen collection/transport compositions and methods |
| US9683256B2 (en) | 2007-10-01 | 2017-06-20 | Longhorn Vaccines And Diagnostics, Llc | Biological specimen collection and transport system |
| US11041215B2 (en) | 2007-08-24 | 2021-06-22 | Longhorn Vaccines And Diagnostics, Llc | PCR ready compositions and methods for detecting and identifying nucleic acid sequences |
| DK2535428T3 (en) | 2007-10-01 | 2015-11-23 | Longhorn Vaccines & Diagnostics Llc | Biological prøvesamlings- and transport system, and methods of using |
| US11041216B2 (en) | 2007-10-01 | 2021-06-22 | Longhorn Vaccines And Diagnostics, Llc | Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples |
| EP2717055A1 (fr) * | 2012-10-04 | 2014-04-09 | Institut Pasteur | Utilisation des bactéries de leptospira fainei serovar Hurstbridge pour le diagnostic de la leptospirose |
| GB201410118D0 (en) * | 2014-06-06 | 2014-07-23 | Sec Dep For Health The | Early diagnosis of leptospire |
| RU2607006C1 (ru) * | 2016-03-03 | 2017-01-10 | Федеральное бюджетное учреждение науки "Санкт-Петербургский научно-исследовательский институт эпидемиологии и микробиологии им. Пастера" (ФБУН НИИ эпидемиологии и микробиологии имени Пастера) | Тест-штамм Leptospira interrogans серогруппы Icterohaemorrhagiae серовара copenhageni для детекции антител к L. icterohaemorrhagiae |
| RU2768008C1 (ru) * | 2021-06-21 | 2022-03-22 | Федеральное бюджетное учреждение науки "Санкт-Петербургский научно-исследовательский институт эпидемиологии и микробиологии им. Пастера Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека" (ФБУН НИИ эпидемиологии и микробиологии имени Пастера) | Вирулентный штамм бактерий Leptospira interrogans серогруппы Icterohaemorrhagiae серовара copenhageni, используемый для экспериментального изучения лептоспирозной инфекции |
-
1997
- 1997-03-07 AU AUPO5494A patent/AUPO549497A0/en not_active Abandoned
-
1998
- 1998-03-06 WO PCT/AU1998/000145 patent/WO1998040099A1/fr active IP Right Grant
- 1998-03-06 CA CA002283624A patent/CA2283624A1/fr not_active Abandoned
- 1998-03-06 JP JP53896998A patent/JP2002501368A/ja active Pending
- 1998-03-06 NZ NZ337754A patent/NZ337754A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AUPO549497A0 (en) | 1997-03-27 |
| JP2002501368A (ja) | 2002-01-15 |
| WO1998040099A1 (fr) | 1998-09-17 |
| WO1998040099A9 (fr) | 1999-10-28 |
| CA2283624A1 (fr) | 1998-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ337754A (en) | Leptospira pathogens belonging to the serogroup Hurstbridge or serovar Hurstbridge | |
| GR3031716T3 (en) | Immunogens against gonadotropin releasing hormone | |
| PL318930A1 (en) | Mutant enterotoxin effective as a non-toxic adjutant | |
| EP0871735A4 (fr) | Compositions therapeutiques et diagnostiques | |
| MX9203278A (es) | Pastilla de liberacion sustentada que comprende loratadina, ibuprofen y pseudoefedrina. | |
| EP0672116A4 (fr) | Mutants de deletion utilises en tant que vaccins contre le cholera. | |
| MY104535A (en) | Oral composition for the treatment of inflammatory bowel diseases. | |
| ES2149776T3 (es) | Modulacion, inducida por un morfogeno, de la respuesta inflamatoria. | |
| BR0209662A (pt) | Método para o tratamento e/ou profilaxia de condições caracterizadas pela função alterada de instestino e/ou dor visceral em seres humanos ou mamìferos não humanos | |
| CA2408537A1 (fr) | Traitement du syndrome ou de la maladie du colon irritable | |
| CA2270821A1 (fr) | Dispositif vaginal utilise en contraception ou dans la prevention de la transmission des maladies sexuellement transmissibles, ou les deux | |
| YU7699A (sh) | Lečenje prehlade ili alergijskog rinitisa | |
| TR200100948T2 (tr) | Cinsel yoldan bulaşan hastalıklara karşı aşı | |
| EP1017714A4 (fr) | PRODUITS DE SYNTHESE PEPTIDIQUES PERMETTANT LE DIAGNOSTIC ET LE TRAITEMENT DE LA DESMODONTITE ASSOCIEE A LA $i(PORPHYROMONAS GINGIVALIS) | |
| EP0837692A4 (fr) | ||
| Pal et al. | Immunization with the Chlamydia trachomatis major outer membrane protein, using the outer surface protein A of Borrelia burgdorferi as an adjuvant, can induce protection against a chlamydial genital challenge | |
| BR9504573A (pt) | Formulaçao farmaceutica adequada para fabricaçao de tabletes dispersiveis por compressao direta tablete de cefaclor dispersivel e processo para fabricaçao de um tablete dispersivel contendo cefaclor | |
| ZA972757B (en) | Porphyromonas gingivalis antigents for the diagnosis and treatment of periodontitis. | |
| NO983672L (no) | Prevensjonssystem med antibakteriell effekt og/eller antiviruseffekt | |
| DE10399019I2 (de) | Gefl}gelkrankheit verursachende neue Bakterie und daraus stammender Impfstoff. | |
| IL111101A0 (en) | Composition containing lectins for contraception and prophylaxis against diseases transmittable by sexual contact and apparatus for administering lectins | |
| IL123922A (en) | Detection, prevention and treatment of papillomatous digital dermatitis in ruminants comprising a therapeutically effective amount of serpens spp | |
| DE69429521T2 (de) | Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung | |
| HUP9700975A2 (hu) | Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok | |
| HK1012404A1 (en) | Extraction of cell-bound protein from bordetella |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RENW | Renewal (renewal fees accepted) | ||
| ASS | Change of ownership |
Owner name: AUSTRALIAN PORK LIMITED, AU Free format text: OLD OWNER(S): PIG RESEARCH AND DEVELOPMENT CORPORATION; AGRICULTURE VICTORIA SERVICES PTY LTD Owner name: AGRICULTURE VICTORIA SERVICES PTY LTD, AU Free format text: OLD OWNER(S): PIG RESEARCH AND DEVELOPMENT CORPORATION; AGRICULTURE VICTORIA SERVICES PTY LTD |
|
| RENW | Renewal (renewal fees accepted) |